David Dowdy
#128,715
Most Influential Person Now
Researcher
David Dowdy's AcademicInfluence.com Rankings
David Dowdymedical Degrees
Medical
#2280
World Rank
#2693
Historical Rank
Public Health
#459
World Rank
#474
Historical Rank
Epidemiology
#567
World Rank
#591
Historical Rank
David Dowdyphilosophy Degrees
Philosophy
#10072
World Rank
#13771
Historical Rank
Logic
#7012
World Rank
#8615
Historical Rank
Download Badge
Medical Philosophy
David Dowdy's Degrees
- Doctorate Medicine University of California, San Francisco
- Masters Public Health Johns Hopkins University
- PhD Epidemiology Johns Hopkins University
Why Is David Dowdy Influential?
(Suggest an Edit or Addition)According to Wikipedia, David Wesley Dowdy is an American infectious disease epidemiologist. He is the B. Frank and Kathleen Polk Professor at Johns Hopkins Bloomberg School of Public Health. Early life and education Dowdy earned his Bachelor of Science degree from Duke University in 1999 before enrolling at Johns Hopkins Bloomberg School of Public Health for his Master's degree, PhD, and Medical degree. He completed his PhD under the guidance of Richard Chaisson, a tuberculosis and HIV expert, who encouraged him to study epidemiological modeling of tuberculosis.
David Dowdy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection (2014) (648)
- Quality of life in adult survivors of critical illness: A systematic review of the literature (2005) (509)
- Neuromuscular dysfunction acquired in critical illness: a systematic review (2007) (462)
- Physical Complications in Acute Lung Injury Survivors: A Two-Year Longitudinal Prospective Study (2014) (460)
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. (2017) (447)
- Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa (2009) (421)
- Adherence to Nonnucleoside Reverse Transcriptase InhibitorBased HIV Therapy and Virologic Outcomes (2007) (380)
- Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials (2014) (330)
- Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults (2006) (304)
- Quality of life after acute respiratory distress syndrome: a meta-analysis (2006) (301)
- Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection (2018) (262)
- A call to action for comprehensive HIV services for men who have sex with men (2012) (260)
- Sudden cardiac death in patients with human immunodeficiency virus infection. (2012) (242)
- Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission (2018) (193)
- Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? (2014) (158)
- The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis (2020) (156)
- What We Know About Tuberculosis Transmission: An Overview (2017) (145)
- Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models (2016) (134)
- Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics (2012) (132)
- The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis (2020) (117)
- Understanding the incremental value of novel diagnostic tests for tuberculosis (2015) (110)
- Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. (2013) (107)
- Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis (2009) (102)
- Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing (2008) (97)
- Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis (2011) (96)
- Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. (2012) (96)
- Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis (2015) (96)
- Study protocol: The Improving Care of Acute Lung Injury Patients (ICAP) study (2005) (96)
- The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model (2015) (92)
- Breaking the Translational Barriers: The Value of Integrating Biomedical Informatics and Translational Research (2005) (88)
- Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults (2008) (86)
- Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. (2014) (85)
- Data for action: collection and use of local data to end tuberculosis (2015) (85)
- Neuromuscular dysfunction acquired during critical illness: a systematic review (2007) (84)
- Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study (2017) (82)
- The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model (2006) (81)
- The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States. (2016) (80)
- The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. (2009) (79)
- Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. (2008) (79)
- How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India (2014) (78)
- Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. (2016) (74)
- Timing of tuberculosis transmission and the impact of household contact tracing. An agent-based simulation model. (2014) (71)
- Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States. (2013) (69)
- Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis (2011) (66)
- Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury* (2008) (66)
- Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults (2008) (64)
- Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach (2017) (62)
- Studying outcomes of intensive care unit survivors: measuring exposures and outcomes (2005) (60)
- Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. (2014) (58)
- Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. (2013) (58)
- Are intensive care factors associated with depressive symptoms 6 months after acute lung injury?* (2009) (57)
- Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making (2014) (55)
- Serological tests for the diagnosis of active tuberculosis: relevance for India (2012) (54)
- Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making (2015) (54)
- The impact of new tuberculosis diagnostics on transmission: why context matters. (2012) (53)
- Widespread use of serological tests for tuberculosis: data from 22 high-burden countries (2012) (52)
- Cost-Effectiveness Analysis of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test as Used Routinely on Smear-Positive Respiratory Specimens (2003) (52)
- The Importance of Heterogeneity to the Epidemiology of Tuberculosis (2018) (51)
- The Importance of Implementation Strategy in Scaling Up Xpert MTB/RIF for Diagnosis of Tuberculosis in the Indian Health-Care System: A Transmission Model (2014) (50)
- Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'. (2013) (49)
- Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis (2006) (48)
- Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis (2016) (47)
- Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study (2017) (45)
- Understanding the Disparity: Predictors of Virologic Failure in Women Using Highly Active Antiretroviral Therapy Vary by Race and/or Ethnicity (2013) (45)
- Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice Experiment (2019) (45)
- The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis. (2015) (44)
- The Epidemiological Importance of Subclinical Tuberculosis: A Critical Re-Appraisal. (2020) (43)
- Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency department. (2011) (43)
- The epidemiological advantage of preferential targeting of tuberculosis control at the poor. (2015) (40)
- Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study. (2016) (40)
- Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings (2018) (40)
- Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic Review (2017) (38)
- Economic Evaluation of Laboratory Testing Strategies for Hospital-Associated Clostridium difficile Infection (2013) (38)
- Modelling the social and structural determinants of tuberculosis: opportunities and challenges (2017) (37)
- Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. (2019) (36)
- Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis? (2014) (36)
- Severe mental illness at ART initiation is associated with worse retention in care among HIV‐infected Ugandan adults (2013) (35)
- Transforming the fight against tuberculosis: targeting catalysts of transmission. (2014) (35)
- Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis (2020) (35)
- Rapid Molecular Testing for TB to Guide Respiratory Isolation in the U.S.: A Cost-Benefit Analysis (2013) (34)
- Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list' [Review article]. (2013) (34)
- Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda (2013) (34)
- Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. (2013) (34)
- MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis (2017) (33)
- Mortality Associated With Delays Between Clinic Entry and ART Initiation in Resource-Limited Settings: Results of a Transition–State Model (2013) (33)
- Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia. (2013) (32)
- Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis (2017) (32)
- What if They Don’t Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis (2018) (31)
- Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study (2017) (31)
- Problems with condom use not unusual among men who have sex with men. (2014) (31)
- Costing the implementation of public health interventions in resource-limited settings: a conceptual framework (2020) (31)
- Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation. (2019) (30)
- Population-Level Impact of Active Tuberculosis Case Finding in an Asian Megacity (2013) (29)
- Yield and Efficiency of Novel Intensified Tuberculosis Case‐Finding Algorithms for People Living with HIV (2019) (29)
- Higher cost of implementing Xpert(®) MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness. (2016) (28)
- Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests. (2019) (28)
- How can mathematical models advance tuberculosis control in high HIV prevalence settings? (2014) (28)
- Performance of a Novel Algorithm Using Automated Digital Microscopy for Diagnosing Tuberculosis. (2015) (28)
- Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study (2017) (27)
- Impact of Isoniazid Preventive Therapy for HIV-Infected Adults in Rio de Janeiro, Brazil: An Epidemiological Model (2014) (27)
- Screening for active tuberculosis: methodological challenges in implementation and evaluation. (2013) (27)
- Yield of household contact tracing for tuberculosis in rural South Africa (2018) (26)
- Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa (2013) (26)
- Risk factors for catastrophic costs associated with tuberculosis in rural South Africa. (2019) (26)
- Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies (2015) (25)
- Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB) (2019) (25)
- Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review. (2018) (25)
- Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis (2016) (25)
- Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations (2014) (25)
- Effects of nelfinavir and its M8 metabolite on lymphocyte P‐glycoprotein activity during antiretroviral therapy (2003) (25)
- Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda. (2015) (24)
- Studying outcomes of intensive care unit survivors: the role of the cohort study (2005) (24)
- Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men (2017) (24)
- Latent Tuberculosis: Models, Computational Efforts and the Pathogen’s Regulatory Mechanisms during Dormancy (2013) (24)
- The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. (2017) (24)
- Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective (2019) (24)
- The public health response to COVID-19: balancing precaution and unintended consequences (2020) (24)
- An agent-based simulation of a Tuberculosis epidemic: Understanding the timing of transmission (2013) (24)
- Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries (2019) (23)
- C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings (2015) (23)
- Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths (2015) (23)
- The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. (2017) (23)
- Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis (2017) (23)
- Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas (2017) (23)
- A Systematic Review to Evaluate the Association between Clean Cooking Technologies and Time Use in Low- and Middle-Income Countries (2019) (22)
- Cost-effectiveness of novel first-line treatment regimens for tuberculosis. (2013) (22)
- Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. (2011) (21)
- Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study. (2014) (21)
- Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial (2020) (21)
- Screening for Tuberculosis With Xpert MTB/RIF Assay Versus Fluorescent Microscopy Among Adults Newly Diagnosed With Human Immunodeficiency Virus in Rural Malawi: A Cluster Randomized Trial (Chepetsa) (2018) (21)
- Improving active case finding for tuberculosis in South Africa: informing innovative implementation approaches in the context of the Kharitode trial through formative research (2017) (21)
- How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis. (2016) (21)
- Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model (2016) (20)
- Test and Treat: A New Standard for Smear-Positive Tuberculosis (2012) (20)
- How Do Urban Indian Private Practitioners Diagnose and Treat Tuberculosis? A Cross-Sectional Study in Chennai (2016) (20)
- Partnership as an ethical model for medical research in developing countries: the example of the “implementation trial” (2006) (20)
- Home-based tuberculosis contact investigation in Uganda: a household randomised trial (2019) (20)
- A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis (2016) (20)
- What will it take to eliminate drug-resistant tuberculosis? (2019) (19)
- Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model (2017) (19)
- Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis (2014) (18)
- Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis (2015) (18)
- Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized Trial (2017) (18)
- Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model (2019) (18)
- Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling (2014) (18)
- Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses (2019) (17)
- Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India (2015) (17)
- Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment. (2017) (17)
- The potential impact of the COVID-19 pandemic on tuberculosis: a modelling analysis (2020) (17)
- Effect of 2 Integrated Interventions on Alcohol Abstinence and Viral Suppression Among Vietnamese Adults With Hazardous Alcohol Use and HIV (2020) (16)
- Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. (2018) (16)
- Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi. (2018) (16)
- Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas. (2020) (16)
- Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda (2020) (16)
- Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective. (2017) (16)
- Fever is associated with delayed ventilator liberation in acute lung injury. (2013) (16)
- Erratum: Studying outcomes of intensive care unit survivors: The role of the cohort study (Intensive Care Medicine (2005) 31 (914-921) DOI: 10.1007/s00134-005-2657-6) (2005) (16)
- Mathematical Modeling of “Chronic” Infectious Diseases: Unpacking the Black Box (2017) (16)
- Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We’re There? (2017) (16)
- Modelling the impact of social protection on tuberculosis: the S-PROTECT project (2018) (15)
- Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India (2016) (15)
- Maternal priorities for preventive therapy among HIV‐positive pregnant women before and after delivery in South Africa: a best–worst scaling survey (2018) (15)
- Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US (2020) (15)
- Screening for tuberculosis: time to move beyond symptoms. (2019) (15)
- Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis. (2017) (15)
- Siyaphambili protocol: An evaluation of randomized, nurse‐led adaptive HIV treatment interventions for cisgender female sex workers living with HIV in Durban, South Africa (2019) (15)
- Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic. (2020) (15)
- The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases. (2012) (15)
- Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy (2017) (15)
- Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis (2017) (14)
- Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis. (2013) (13)
- Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil. (2013) (13)
- Economic and epidemiological impact of early antiretroviral therapy initiation in India (2015) (13)
- Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines? (2015) (13)
- The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa (2015) (13)
- The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities. (2020) (13)
- Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB) (2020) (13)
- 'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda. (2018) (13)
- A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis (2014) (13)
- Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain (2018) (13)
- Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis (2014) (13)
- Are we underestimating the annual risk of infection with Mycobacterium tuberculosis in high-burden settings? (2022) (12)
- Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis. (2014) (12)
- Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis (2016) (12)
- Aminoglycoside-Induced Hearing Loss Among Patients Being Treated for Drug-Resistant Tuberculosis in South Africa: A Prediction Model. (2019) (12)
- Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda (2020) (11)
- Impact and Effectiveness of State-level Tuberculosis interventions in California, Florida, New York and Texas: A model-based analysis. (2019) (11)
- Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis (2019) (10)
- Screening for active tuberculosis: methodological challenges in implementation and evaluation [State of the art series. Active case finding/screening. Number 4 in the series]. (2013) (10)
- Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up (2019) (10)
- Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost‐effectiveness from a national and regional perspective (2020) (10)
- Bridging the gap between knowledge and health: the epidemiologist as Accountable Health Advocate ("AHA!"). (2012) (10)
- Studying outcomes of intensive care unit survivors: the role of the cohort study (2005) (10)
- Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic (2011) (9)
- 70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration. (2019) (9)
- Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. (2019) (9)
- Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose. (2020) (9)
- Evaluation of Health Promotion and Disease Prevention Programs. (2015) (9)
- Cost-effectiveness of Diagnostic Algorithms for Tuberculosis in Children Less Than 5 Years of Age (2017) (9)
- Tuberculosis patients with higher levels of poverty face equal or greater costs of illness. (2019) (9)
- Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. (2020) (9)
- Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study (2017) (9)
- Determining the value of TB active case-finding: current evidence and methodological considerations. (2021) (8)
- Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model (2018) (8)
- Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa. (2018) (8)
- What Will It Take to Reduce HIV Incidence in the United States: A Mathematical Modeling Analysis (2018) (8)
- From Epidemiological Knowledge to Improved Health: A Vision for Translational Epidemiology. (2019) (8)
- The impact of novel tests for tuberculosis depends on the diagnostic cascade (2014) (8)
- Tobacco smoking and bladder cancer. (2011) (8)
- Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries. (2020) (8)
- Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment (2018) (8)
- Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis. (2016) (8)
- Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment (2016) (8)
- Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults (2016) (7)
- A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa (2020) (7)
- Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi (2018) (7)
- Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis (2014) (7)
- Cost-Consequence Analysis of Multimodal Interventions with Environmental Components for Pediatric Asthma in the State of Maryland (2013) (7)
- A Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data Collection (2015) (7)
- Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting (2019) (7)
- Brief Report: “Give Me Some Time” Facilitators of and Barriers to Uptake of Home-Based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda (2018) (7)
- Spatial distribution of people diagnosed with tuberculosis through routine and active case finding: a community-based study in Kampala, Uganda (2020) (7)
- Risk factors for delirium: are systematic reviews enough?. (2015) (7)
- Towards evidence‐based integration of services for HIV, non‐communicable diseases and substance use: insights from modelling (2020) (7)
- Multidrug-resistant tuberculosis in India: looking back, thinking ahead. (2017) (6)
- Priorities among HIV-positive individuals for tuberculosis preventive therapies. (2020) (6)
- What Will It Take to End HIV in the United States? (2021) (6)
- Drug-resistant tuberculosis in 2017: at a crossroads. (2017) (6)
- Alcohol abstinence stigma and alcohol use among HIV patients in Thai Nguyen, Vietnam (2020) (6)
- Patient Follow-up in an Urban Resident Continuity Clinic: An Initiative to Improve Scheduling Practices. (2011) (6)
- The longitudinal association between depression, anxiety symptoms and HIV outcomes, and the modifying effect of alcohol dependence among ART clients with hazardous alcohol use in Vietnam (2021) (6)
- Estimating the proportion of tuberculosis recent transmission via simulation (2014) (6)
- Evaluating the cost of adult voluntary medical male circumcision in a mixed (surgical and PrePex) site compared to a hypothetical PrePex-only site in South Africa (2015) (6)
- Economic evaluations of point of care testing strategies for active tuberculosis (2013) (6)
- Linking Individual Natural History to Population Outcomes in Tuberculosis (2017) (6)
- Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia (2021) (6)
- Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda (2021) (6)
- Antigen-based rapid diagnostic testing or alternatives for diagnosis of symptomatic COVID-19: A simulation-based net benefit analysis (2020) (6)
- Would pan-tuberculosis treatment regimens be cost-effective? (2018) (5)
- Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas, 2011-2015 (2018) (5)
- [The epidemiological advantage of preferential targeting of tuberculosis control at the poor]. (2015) (5)
- Characterization of geographic mobility among participants in facility- and community-based tuberculosis case finding in urban Uganda (2021) (5)
- Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study (2019) (5)
- HIV in men who have sex with men 6 A call to action for comprehensive HIV services for men who have sex with men (2012) (5)
- Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis (2021) (5)
- Implementation of two alcohol reduction interventions among persons with hazardous alcohol use who are living with HIV in Thai Nguyen, Vietnam: a micro-costing analysis (2020) (5)
- Quantifying geographic heterogeneity in TB incidence and the potential impact of geographically targeted interventions in South and North City Corporations of Dhaka, Bangladesh: a model-based study (2020) (5)
- Achieving a “step change” in the tuberculosis epidemic through comprehensive community-wide intervention: a model-based analysis (2021) (5)
- Trained to Avoid Primary Care (2011) (5)
- The effect of partner HIV status on motivation to take antiretroviral and isoniazid preventive therapies: a conjoint analysis (2018) (5)
- Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda (2020) (5)
- Data Needs for Evidence-Based Decisions: A TB Modeler’s “Wish List” (2014) (5)
- Quality of life in adult survivors of critical illness: A systematic review of the literature (2005) (5)
- EFFECT of reductions in OPIOID prescribing on opioid use disorder and fatal overdose in the united states: A dynamic Markov model. (2021) (5)
- Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion (2020) (5)
- Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries (2021) (5)
- Cost‐effectiveness of a 12 country‐intervention to scale up short course TB preventive therapy among people living with HIV (2020) (4)
- Evidence-based COVID-19 policy-making in schools (2021) (4)
- Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis (2020) (4)
- Projecting the impact of variable MDR-TB transmission efficiency on long-term epidemic trends in South Africa and Vietnam (2019) (4)
- Tuberculosis: progress and challenges in product development and delivery. (2014) (4)
- Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy. (2020) (4)
- Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations (2019) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- The Potential Impact of the COVID-19 Pandemic on the Tuberculosis Epidemic: A Modelling Analysis (2020) (4)
- A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens. (2016) (4)
- Improving the US Health Care System: Action Plan to Enhance Efficiency, Reduce Errors, and Improve Quality (2003) (4)
- Late Breaking Abstract - The tuberculosis diagnostic evaluation cascade of care at microscopy centers linked to Xpert MTB/RIF hubs in Uganda (2017) (4)
- Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda. (2022) (4)
- Tests for latent tuberculosis infection and isoniazid preventive therapy. (2012) (4)
- Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda (2020) (4)
- Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics (2020) (4)
- The Cost-Effectiveness of Adapting and Implementing a Brief Intervention to Target Frequent Alcohol Use Among Persons with HIV in Vietnam (2021) (4)
- Antigen-based Rapid Diagnostic Testing or Alternatives for Diagnosis of Symptomatic COVID-19 (2021) (4)
- Patient‐incurred cost of inpatient treatment for Tuberculosis in rural Malawi (2020) (3)
- Comparing a standard and tailored approach to scaling up an evidence-based intervention for antiretroviral therapy for people who inject drugs in Vietnam: study protocol for a cluster randomized hybrid type III trial (2020) (3)
- Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil [Short communication]. (2013) (3)
- Completion of isoniazid–rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness–implementation randomized trial (2021) (3)
- Economic analyses of diagnostics for tuberculosis: what’s the point? (2012) (3)
- Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives (2020) (3)
- Aligning New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Needs Assessment and Roadmap for Action (2014) (3)
- A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations (2022) (3)
- Thinking outside the box: intensive care unit diaries to improve psychological outcomes in family members*. (2012) (3)
- Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa. (2020) (3)
- Minding the Gap: Specimen Referral Systems for Diagnosis of Infectious Diseases. (2016) (3)
- Chest X-ray for tuberculosis preventive therapy: use caution. (2018) (2)
- Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review (2022) (2)
- Setting clinical priorities: a framework for incorporating individual patient preferences. (2013) (2)
- A cost analysis of implementing mobile health facilitated tuberculosis contact investigation in a low-income setting (2022) (2)
- Sensitivity of Direct Versus Concentrated Sputum Smear Microscopy in HIV-Infected Persons Suspected of Having Pulmonary Tuberculosis. (2009) (2)
- Symptom and digital chest X-ray TB screening in South African prisons: yield and cost-effectiveness. (2020) (2)
- Symptom-based vs asymptomatic testing for controlling SARS-CoV-2 transmission in low- and middle-income countries: A modelling analysis (2022) (2)
- Validating novel diagnostic assays for tuberculosis in the context of existing tools (2021) (2)
- Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach (2022) (2)
- Incorporating Patient Reporting Patterns to Evaluate Spatially Targeted TB Interventions. (2020) (2)
- Ending the Human Immunodeficiency Virus Epidemic: Towards an Evidence-Based Approach (2019) (2)
- Health‐related quality of life of female sex workers living with HIV in South Africa: a cross‐sectional study (2022) (2)
- Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives. (2019) (2)
- Health-related quality of life of inpatients and outpatients with TB in rural Malawi. (2020) (2)
- Exploring the epidemiological impact of universal access to rapid tuberculosis diagnosis using agent-based simulation (2017) (2)
- Point-of-Care Tests for HIV, Related Coinfections, and Blood-Borne Infections (2014) (2)
- Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities (2022) (2)
- Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination (2020) (2)
- Potential Effects of the COVID-19 Pandemic on HIV Transmission: A Modeling Study in 32 US Cities. (2022) (2)
- Correction: Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men (2017) (2)
- Cost-effectiveness analysis of human-centred design for global health interventions: a quantitative framework (2022) (2)
- Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model. (2019) (1)
- Clinical impact of rapid drug susceptibility testing to accompany fluoroquinolone-containing universal tuberculosis regimens: a Markov model. (2019) (1)
- Bold thinking for bold results: modeling the elimination of tuberculosis. (2014) (1)
- Post-2015 tuberculosis strategies in a pre-2015 world. (2013) (1)
- Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies (2023) (1)
- Reply to Pierce: Subclinical Tuberculosis: Some Flies in the Ointment (2021) (1)
- Reply to Anthony et al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment” (2017) (1)
- Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation (2018) (1)
- Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial (2021) (1)
- Quantifying the impact of the National HIV / AIDS strategy targets for improved HIV care engagement in the US : a modelling study (1)
- Basic and Descriptive Epidemiology of Tuberculosis (2021) (1)
- The epidemiologist as Accountable Health Advocate ("AHA!"): a useful model for promoting health. (2012) (1)
- Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics (2022) (1)
- Tuberculosis control in crisis: economic honesty and comparative effectiveness. (2012) (1)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- 683: Cost effectiveness of reducing CLABSI in the limited resource setting of developing countries (2013) (1)
- The eye of the beholder: tuberculosis screening for elderly long-term care residents. (2013) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- Sub-district level correlation between tuberculosis notifications and socio-demographic factors in Dhaka City corporation, Bangladesh (2021) (1)
- Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentine (2023) (1)
- Measuring success: The challenge of social protection in helping eliminate tuberculosis (2017) (1)
- The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection. (2019) (1)
- Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects (2022) (1)
- Effects of Two Alcohol Reduction Interventions on Depression and Anxiety Symptoms of ART Clients in Vietnam (2021) (1)
- Implementation of Xpert® MTB/RIF: real challenges, real promise. (2019) (1)
- Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees (2021) (1)
- Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing (2016) (1)
- Cost-effectiveness of universal HIV testing and treatment: where next? (2021) (1)
- Cost-Effectiveness of Novel First-Line Therapeutic Regimens for Tuberculosis (2013) (1)
- Conditional cash transfers to incentivize tuberculosis screening: Description of a novel strategy for contact investigation in rural South Africa. (2021) (1)
- Evaluating the effects of two alcohol reduction counseling interventions on intimate partner violence perpetration: Secondary analysis of a three-arm randomized controlled trial among Vietnamese men with HIV. (2021) (1)
- Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis (2023) (1)
- Coughing Is Not Required to Transmit Mycobacterium tuberculosis: Another Nail in the Coffin (2022) (1)
- Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial (2022) (1)
- How much is TB Screening Worth ? Estimating the Value of Active Case Finding for Tuberculosis in South Africa , China , and India . Supporting Information (2014) (1)
- Infection status of contacts is not associated with severity of TB in the index case. (2021) (1)
- Costs along the TB diagnostic pathway in Uganda. (2021) (1)
- Health-related quality of life of female sex workers living with HIV in South Africa (2021) (1)
- Alcohol use, depressive symptoms, and intimate partner violence perpetration: A longitudinal analysis among men with HIV in northern Vietnam (2020) (0)
- Estimating annual risk of infection with Mycobacterium tuberculosis - Authors' reply. (2022) (0)
- The path to TB Elimination: a renewed vision. (2023) (0)
- Design and execution of a public randomization ceremony to enhance stakeholder engagement within a cluster randomized trial to improve tuberculosis diagnosis in Uganda (2021) (0)
- Public Health Issues (2017) (0)
- Costs along the diagnostic pathway for TB in Uganda (2021) (0)
- Proportion and predictors of adult TB contacts accepting HIV testing during an active TB case finding intervention in South Africa. (2020) (0)
- Title Differentiated care preferences of stable patients o ART in Zambia : A discrete choice experiment (2019) (0)
- Projecting the impact of implementing pre-exposure prophylaxis for HIV among men who have sex with men in Baltimore city (2015) (0)
- Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications. (2022) (0)
- Household versus incentive-based contact investigation for tuberculosis in rural South Africa: a cluster-randomized trial. (2022) (0)
- A controlled study to assess the effects of a Fast Track (FT) service delivery model among stable HIV patients in Lusaka Zambia (2022) (0)
- Modelling the social and structural determinants of TB: opportunities and challenges (2017) (0)
- Microcirculation in the ICU : A Small Step for Monitoring , a Giant Leap for Tissue Viability (2014) (0)
- A piece of my mind. Healthy but harmed. (2014) (0)
- Phosphatidylethanol and self-reported alcohol consumption among people living with HIV in Thai Nguyen, Vietnam. (2023) (0)
- Estimated Population-level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. (2020) (0)
- Assessing the Impact of Targeted Screening and Treatment of Diabetes and Hypertension Among Adults Living with HIV in Nairobi, Kenya (2020) (0)
- Widespread Abuse Of Serological Testing For Active TB In India: More Costly And Less Effective (2011) (0)
- Has the COVID-19 pandemic increased tuberculosis mortality? (2022) (0)
- Social support modifies the association between hazardous drinking and depression symptoms among ART clients in Vietnam. (2020) (0)
- Clostridium difficile Infection Strategies for Hospital-Associated Economic Evaluation of Laboratory Testing (2014) (0)
- Decline in prevalence of tuberculosis following an intensive case-finding campaign and the COVID-19 pandemic in an urban Ugandan community (2023) (0)
- Ending the HIV Epidemic: Towards an Evidence-Based Approach. (2019) (0)
- Working title: Health-related quality of life of female sex workers living with HIV in South Africa (2021) (0)
- International Journal of Life science and Pharma Research Tuberculosis the Lernaean Hydra of 21st Century - A Post Covid Update on the Indian Scenario (2022) (0)
- Impact and cost -effectiveness of improved diagnostics for tuberculosis in high-burden countries (2008) (0)
- Epidemiology in History Seventy Years of Tuberculosis Prevention: Ef fi cacy, Effectiveness, Toxicity, Durability, and Duration (2019) (0)
- Longitudinal analysis of alcohol use and intimate partner violence perpetration among men with HIV in northern Vietnam. (2020) (0)
- In reply. (2015) (0)
- CKD and Risk of Incident Hospitalization With Clostridioides Difficile Infection: Findings From the Atherosclerosis Risk in Communities (ARIC) Study (2021) (0)
- Author response: A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis (2014) (0)
- Cost-Benefit Analysis Of GeneXpert MTB/RIF For Evaluation Of Infectious Tuberculosis At An Urban Public Hospital (2012) (0)
- Standardized framework for evaluating the cost-effectiveness of tuberculosis (TB) casefinding and treatment initiation projects in TB REACH Wave 5 Draft Report the Stop TB Partnership (2020) (0)
- Health-related quality of life of inpatients and outpatients treated for tuberculosis in rural Malawi (2021) (0)
- Time to care-seeking for TB symptoms. (2022) (0)
- Adaptive strategies for the deployment of rapid diagnostic tests for COVID-19: a modelling study (2023) (0)
- Low prevalence of diabetes mellitus among tuberculosis patients and their community in urban Uganda (2021) (0)
- Multidrug-Resistant Tuberculosis Treatment as Prevention: Modeling the Population-Level Impact of Expanded Treatment for Multidrug-Resistant Tuberculosis (2015) (0)
- Projecting the population-level impact of pre-exposure prophylaxis for HIV among men who have sex with men in Baltimore city (2016) (0)
- Refocusing the timeline of tuberculosis through the lens of BCG (2021) (0)
- Original Contribution Impact of Targeted Tuberculosis Vaccination Among aMining Population in South Africa: AModel-Based Study (2017) (0)
- Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB). (2022) (0)
- RE: Severe mental illness at ART initiation is associated with worse retention in care among HIV‐infected Ugandan adults by JM Nachega et al. (2013), TMIH 18, pp 53–57 (2014) (0)
- Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda (2022) (0)
- Evaluating the cost of adult voluntary medical male circumcision in a mixed (surgical and PrePex) site compared to a hypothetical PrePex-only site in South Africa (2015) (0)
- Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas. (2022) (0)
- Understanding the drivers of drug resistance in tuberculosis A multi-strain mathematical model (2016) (0)
- Additional file 1: of Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis (2016) (0)
- Tuberculosis control in crisis: economic honesty and comparative effectiveness [Correspondence]. (2012) (0)
- Understanding the net benefit of antigen-based rapid diagnostic tests for COVID-19: An enhanced decision-curve analysis (2020) (0)
- Spatial distribution of TB among individuals with a history of incarceration. (2021) (0)
- Geographic mobility and time to seeking care among people with TB in Limpopo, South Africa. (2021) (0)
- The changing views of health promotion amoung HIV-infected pregnant women in South Africa before and after delivery: A choice experiment (2017) (0)
- Human resource time commitments and associated costs of Community Caregiver outreach team operations in South Africa (2023) (0)
- Erratum: The epidemiological advantage of preferential targeting of tuberculosis at the poor (International Journal of Tuberculosis and Lung Disease (2015) 19:4 (375-380)) (2015) (0)
- The urgent need to improve clinical practice guidelines for pediatric tuberculosis. (2020) (0)
- Priorities for preventive therapies for tuberculosis among HIV-positive individuals in South Africa (2020) (0)
- Reply to Chen, Song, and Liu. (2020) (0)
- “Something So Hard”: A Mixed-Methods Study of Home Sputum Collection for TB Contact Investigation in Uganda (2019) (0)
- Cost-Effectiveness of Point-of-Care Versus Centralized, Laboratory-Based Nucleic Acid Testing for Infant Diagnosis of HIV: A Systematic Overview and Narrative Synthesis of Mathematical Modelling Studies (2022) (0)
- ' s response to reviews Title : How much is TB Screening Worth ? Estimating the Value of Active Case Finding for Tuberculosis in South Africa , China , and India (2014) (0)
- Spatial distribution of tuberculosis among individuals with a history of incarceration in an urban Ugandan community (2022) (0)
- Projecting the impact of pre-exposure prophylaxis for HIV prevention in the context of gonorrhea and chlamydia infection (2017) (0)
- Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis (2020) (0)
- An assessment of the laboratory network in Ghana: A national-level ATLAS survey (2019–2020) (2023) (0)
- The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease (2021) (0)
- Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses. (2022) (0)
- Quantifying Mycobacterium tuberculosis transmission dynamics across global settings: a systematic analysis. (2022) (0)
- Trials underestimate the impact of preventive treatment for household contacts exposed to multidrug-resistant tuberculosis: a simulation study (2023) (0)
- Incorporating Patient Reporting Patterns to Evaluate Geographically Targeted Tuberculosis Interventions in Dhaka, Bangladesh (2020) (0)
- Describing the global burden of MDR-TB: missing cases or different metrics? (2017) (0)
- Infection Detection of Mycobacterium tuberculosis Gamma Interferon Release Assays for (2013) (0)
- Data associated with A Comprehensive Snapshot of Tuberculosis Transmission in an Urban Ugandan Community (STOMP-TB Study) (2019) (0)
- Additional file 2: of Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis (2016) (0)
This paper list is powered by the following services:
Other Resources About David Dowdy
What Schools Are Affiliated With David Dowdy?
David Dowdy is affiliated with the following schools:
